The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Neurorehabilitation Therapy Market Research Report 2024

Global Neurorehabilitation Therapy Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1896854

No of Pages : 100

Ask Your Query
Synopsis
Neurorehabilitation is a complex medical process which aims to aid recovery from a nervous system injury, and to minimize and/or compensate for any functional alterations resulting from it.
The global Neurorehabilitation Therapy market was valued at US$ 1053 million in 2023 and is anticipated to reach US$ 1851.2 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
The neurorehabilitation therapy market is driven by a growing prevalence of neurological disorders and the increasing awareness of the importance of rehabilitation in improving the quality of life for affected individuals. Advances in medical technology and therapies, such as robotics, virtual reality, and neurostimulation, have expanded the possibilities for neurorehabilitation, fostering market growth. However, challenges in this market include the high cost of advanced rehabilitation technologies and therapies, limited accessibility to specialized rehabilitation centers in some regions, and the need for skilled healthcare professionals. Additionally, the effectiveness of neurorehabilitation can vary among individuals, making it essential to tailor therapies to each patient's specific needs and conditions. Ongoing research and innovations in both treatment approaches and cost-effective solutions are crucial to addressing these challenges and further advancing the field of neurorehabilitation therapy.
This report aims to provide a comprehensive presentation of the global market for Neurorehabilitation Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurorehabilitation Therapy.
Report Scope
The Neurorehabilitation Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurorehabilitation Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurorehabilitation Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
VISHEE
Beijing Bo'ai Hospital
Beijing Rehabilitation Hospital of Capital Medical University
NCC
CHIEFTAIN
Tongji Hospital
Haobro Medical Device
DIH
Sun Java
Aoyang Health
PKUCare Rehabilitation Hospital
Beijing Puhua International Hospital
Xiangyu Medical
Beijing United Family Rehabilitation Hospital
Bionik Laboratories Corp
BioScience Managers Ltd
Bioventus
DIH (Hocoma AG)
Ekso Bionics Holdings
Eodyne
Neofect
Neuro Rehab VR
Reha Technology AG
Segment by Type
Brain Injury
Spinal Cord Injury
Peripheral Nerve Injury
Other
Segment by Application
General Hospital
Rehabilitation Specialist Hospital
Community Rehabilitation Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurorehabilitation Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurorehabilitation Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Brain Injury
1.2.3 Spinal Cord Injury
1.2.4 Peripheral Nerve Injury
1.2.5 Other
1.3 Market by Application
1.3.1 Global Neurorehabilitation Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 General Hospital
1.3.3 Rehabilitation Specialist Hospital
1.3.4 Community Rehabilitation Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurorehabilitation Therapy Market Perspective (2019-2030)
2.2 Neurorehabilitation Therapy Growth Trends by Region
2.2.1 Global Neurorehabilitation Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neurorehabilitation Therapy Historic Market Size by Region (2019-2024)
2.2.3 Neurorehabilitation Therapy Forecasted Market Size by Region (2025-2030)
2.3 Neurorehabilitation Therapy Market Dynamics
2.3.1 Neurorehabilitation Therapy Industry Trends
2.3.2 Neurorehabilitation Therapy Market Drivers
2.3.3 Neurorehabilitation Therapy Market Challenges
2.3.4 Neurorehabilitation Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurorehabilitation Therapy Players by Revenue
3.1.1 Global Top Neurorehabilitation Therapy Players by Revenue (2019-2024)
3.1.2 Global Neurorehabilitation Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Neurorehabilitation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurorehabilitation Therapy Revenue
3.4 Global Neurorehabilitation Therapy Market Concentration Ratio
3.4.1 Global Neurorehabilitation Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurorehabilitation Therapy Revenue in 2023
3.5 Neurorehabilitation Therapy Key Players Head office and Area Served
3.6 Key Players Neurorehabilitation Therapy Product Solution and Service
3.7 Date of Enter into Neurorehabilitation Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurorehabilitation Therapy Breakdown Data by Type
4.1 Global Neurorehabilitation Therapy Historic Market Size by Type (2019-2024)
4.2 Global Neurorehabilitation Therapy Forecasted Market Size by Type (2025-2030)
5 Neurorehabilitation Therapy Breakdown Data by Application
5.1 Global Neurorehabilitation Therapy Historic Market Size by Application (2019-2024)
5.2 Global Neurorehabilitation Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neurorehabilitation Therapy Market Size (2019-2030)
6.2 North America Neurorehabilitation Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neurorehabilitation Therapy Market Size by Country (2019-2024)
6.4 North America Neurorehabilitation Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurorehabilitation Therapy Market Size (2019-2030)
7.2 Europe Neurorehabilitation Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neurorehabilitation Therapy Market Size by Country (2019-2024)
7.4 Europe Neurorehabilitation Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurorehabilitation Therapy Market Size (2019-2030)
8.2 Asia-Pacific Neurorehabilitation Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neurorehabilitation Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Neurorehabilitation Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurorehabilitation Therapy Market Size (2019-2030)
9.2 Latin America Neurorehabilitation Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neurorehabilitation Therapy Market Size by Country (2019-2024)
9.4 Latin America Neurorehabilitation Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurorehabilitation Therapy Market Size (2019-2030)
10.2 Middle East & Africa Neurorehabilitation Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neurorehabilitation Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Neurorehabilitation Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 VISHEE
11.1.1 VISHEE Company Detail
11.1.2 VISHEE Business Overview
11.1.3 VISHEE Neurorehabilitation Therapy Introduction
11.1.4 VISHEE Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.1.5 VISHEE Recent Development
11.2 Beijing Bo'ai Hospital
11.2.1 Beijing Bo'ai Hospital Company Detail
11.2.2 Beijing Bo'ai Hospital Business Overview
11.2.3 Beijing Bo'ai Hospital Neurorehabilitation Therapy Introduction
11.2.4 Beijing Bo'ai Hospital Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.2.5 Beijing Bo'ai Hospital Recent Development
11.3 Beijing Rehabilitation Hospital of Capital Medical University
11.3.1 Beijing Rehabilitation Hospital of Capital Medical University Company Detail
11.3.2 Beijing Rehabilitation Hospital of Capital Medical University Business Overview
11.3.3 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Introduction
11.3.4 Beijing Rehabilitation Hospital of Capital Medical University Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.3.5 Beijing Rehabilitation Hospital of Capital Medical University Recent Development
11.4 NCC
11.4.1 NCC Company Detail
11.4.2 NCC Business Overview
11.4.3 NCC Neurorehabilitation Therapy Introduction
11.4.4 NCC Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.4.5 NCC Recent Development
11.5 CHIEFTAIN
11.5.1 CHIEFTAIN Company Detail
11.5.2 CHIEFTAIN Business Overview
11.5.3 CHIEFTAIN Neurorehabilitation Therapy Introduction
11.5.4 CHIEFTAIN Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.5.5 CHIEFTAIN Recent Development
11.6 Tongji Hospital
11.6.1 Tongji Hospital Company Detail
11.6.2 Tongji Hospital Business Overview
11.6.3 Tongji Hospital Neurorehabilitation Therapy Introduction
11.6.4 Tongji Hospital Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.6.5 Tongji Hospital Recent Development
11.7 Haobro Medical Device
11.7.1 Haobro Medical Device Company Detail
11.7.2 Haobro Medical Device Business Overview
11.7.3 Haobro Medical Device Neurorehabilitation Therapy Introduction
11.7.4 Haobro Medical Device Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.7.5 Haobro Medical Device Recent Development
11.8 DIH
11.8.1 DIH Company Detail
11.8.2 DIH Business Overview
11.8.3 DIH Neurorehabilitation Therapy Introduction
11.8.4 DIH Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.8.5 DIH Recent Development
11.9 Sun Java
11.9.1 Sun Java Company Detail
11.9.2 Sun Java Business Overview
11.9.3 Sun Java Neurorehabilitation Therapy Introduction
11.9.4 Sun Java Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.9.5 Sun Java Recent Development
11.10 Aoyang Health
11.10.1 Aoyang Health Company Detail
11.10.2 Aoyang Health Business Overview
11.10.3 Aoyang Health Neurorehabilitation Therapy Introduction
11.10.4 Aoyang Health Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.10.5 Aoyang Health Recent Development
11.11 PKUCare Rehabilitation Hospital
11.11.1 PKUCare Rehabilitation Hospital Company Detail
11.11.2 PKUCare Rehabilitation Hospital Business Overview
11.11.3 PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Introduction
11.11.4 PKUCare Rehabilitation Hospital Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.11.5 PKUCare Rehabilitation Hospital Recent Development
11.12 Beijing Puhua International Hospital
11.12.1 Beijing Puhua International Hospital Company Detail
11.12.2 Beijing Puhua International Hospital Business Overview
11.12.3 Beijing Puhua International Hospital Neurorehabilitation Therapy Introduction
11.12.4 Beijing Puhua International Hospital Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.12.5 Beijing Puhua International Hospital Recent Development
11.13 Xiangyu Medical
11.13.1 Xiangyu Medical Company Detail
11.13.2 Xiangyu Medical Business Overview
11.13.3 Xiangyu Medical Neurorehabilitation Therapy Introduction
11.13.4 Xiangyu Medical Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.13.5 Xiangyu Medical Recent Development
11.14 Beijing United Family Rehabilitation Hospital
11.14.1 Beijing United Family Rehabilitation Hospital Company Detail
11.14.2 Beijing United Family Rehabilitation Hospital Business Overview
11.14.3 Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Introduction
11.14.4 Beijing United Family Rehabilitation Hospital Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.14.5 Beijing United Family Rehabilitation Hospital Recent Development
11.15 Bionik Laboratories Corp
11.15.1 Bionik Laboratories Corp Company Detail
11.15.2 Bionik Laboratories Corp Business Overview
11.15.3 Bionik Laboratories Corp Neurorehabilitation Therapy Introduction
11.15.4 Bionik Laboratories Corp Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.15.5 Bionik Laboratories Corp Recent Development
11.16 BioScience Managers Ltd
11.16.1 BioScience Managers Ltd Company Detail
11.16.2 BioScience Managers Ltd Business Overview
11.16.3 BioScience Managers Ltd Neurorehabilitation Therapy Introduction
11.16.4 BioScience Managers Ltd Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.16.5 BioScience Managers Ltd Recent Development
11.17 Bioventus
11.17.1 Bioventus Company Detail
11.17.2 Bioventus Business Overview
11.17.3 Bioventus Neurorehabilitation Therapy Introduction
11.17.4 Bioventus Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.17.5 Bioventus Recent Development
11.18 DIH (Hocoma AG)
11.18.1 DIH (Hocoma AG) Company Detail
11.18.2 DIH (Hocoma AG) Business Overview
11.18.3 DIH (Hocoma AG) Neurorehabilitation Therapy Introduction
11.18.4 DIH (Hocoma AG) Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.18.5 DIH (Hocoma AG) Recent Development
11.19 Ekso Bionics Holdings
11.19.1 Ekso Bionics Holdings Company Detail
11.19.2 Ekso Bionics Holdings Business Overview
11.19.3 Ekso Bionics Holdings Neurorehabilitation Therapy Introduction
11.19.4 Ekso Bionics Holdings Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.19.5 Ekso Bionics Holdings Recent Development
11.20 Eodyne
11.20.1 Eodyne Company Detail
11.20.2 Eodyne Business Overview
11.20.3 Eodyne Neurorehabilitation Therapy Introduction
11.20.4 Eodyne Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.20.5 Eodyne Recent Development
11.21 Neofect
11.21.1 Neofect Company Detail
11.21.2 Neofect Business Overview
11.21.3 Neofect Neurorehabilitation Therapy Introduction
11.21.4 Neofect Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.21.5 Neofect Recent Development
11.22 Neuro Rehab VR
11.22.1 Neuro Rehab VR Company Detail
11.22.2 Neuro Rehab VR Business Overview
11.22.3 Neuro Rehab VR Neurorehabilitation Therapy Introduction
11.22.4 Neuro Rehab VR Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.22.5 Neuro Rehab VR Recent Development
11.23 Reha Technology AG
11.23.1 Reha Technology AG Company Detail
11.23.2 Reha Technology AG Business Overview
11.23.3 Reha Technology AG Neurorehabilitation Therapy Introduction
11.23.4 Reha Technology AG Revenue in Neurorehabilitation Therapy Business (2019-2024)
11.23.5 Reha Technology AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock